zevalin.com
Provided by Alexa ranking, zevalin.com has ranked N/A in N/A and N/A on the world. It is hoted in N/A with IP address 74.220.203.200. The home page has 0 external link.
Category: Alternative Cancer Therapy
Top keyword related from Search Engine of zevalin.com
Traffic Ranks of zevalin.com
Owner: |
N/A |
RANK: |
N/A |
Country code: |
N/A |
Country name: |
N/A |
Rank on country: |
N/A |
Host: |
N/A |
Ip: |
74.220.203.200 |
Ref link: |
|
Extension: |
com |
Top URL related to zevalin.com
-
1. ZEVALIN. -----------------------WARNINGS AND …
Link: https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/125019s227lbl.pdf
Description: WebZevalin is a CD20-directed radiotherapeutic antibody administered as part of the Zevalin therapeutic regimen indicated for the treatment of adult patients with: relapsed or refractory,...
-
2. Zevalin Label - Food and Drug Administration
Link: https://www.accessdata.fda.gov/drugsatfda_docs/label/2009/125019s0156.pdf
Description: WebZevalin is indicated for the treatment of previously untreated follcular NHL in patients who achieve a parial or complete response to first-line chemotherapy.
-
3. Ibritumomab tiuxetan - Wikipedia
Link: https://en.wikipedia.org/wiki/Ibritumomab_tiuxetan
Description: WebIbritumomab tiuxetan (pronounced / ɪbrɪˈtuːmoʊmæb taɪˈʌksɛtæn / [1] ), sold under the trade name Zevalin, is a monoclonal antibody radioimmunotherapy treatment for non-Hodgkin's lymphoma. The drug uses the monoclonal mouse IgG1 antibody ibritumomab in conjunction with the chelator tiuxetan, to which a radioactive isotope (either ...
-
4. Zevalin | European Medicines Agency
Link: https://www.ema.europa.eu/en/medicines/human/EPAR/zevalin
Description: WebZevalin is used in the following groups of patients: patients who have gone into remission (reduction in the number of cancerous cells) after their first ‘induction treatment’ (initial chemotherapy treatment) for lymphoma. Zevalin is given as ‘consolidation therapy’ to improve the remission;
-
5. Zevalin Kit - Uses, Side Effects, and More - WebMD
Link: https://www.webmd.com/drugs/2/drug-32702/zevalin-y-90-intravenous/details
Description: WebFind patient medical information for Zevalin (Y-90) intravenous on WebMD including its uses, side effects and safety, interactions, pictures, warnings and user ratings.
-
6. Zevalin - Lymphoma Info
Link: https://www.lymphomainfo.net/therapy/immunotherapy/zevalin.html
Description: WebZevalin® (ibritumomab tiuxetan) is a form of radioimmunotherapy (a radiolabeled monoclonal antibody) indicated for treatment of patients with relapsed or refractory, low grade or follicular B-cell non-Hodgkin's lymphoma (NHL) or for patients with previously untreated follicular NHL who achieve a partial or complete response to first-line chemoth...
-
7. Zevalin(®) (ibritumomab tiuxetan): After more than a decade of
Link: https://pubmed.ncbi.nlm.nih.gov/27497027/
Description: WebZevalin (®) (ibritumomab tiuxetan) is a radioactive drug product, which is the combination of a β-emitting isotope, (90)Y, linked to the anti-CD20 monoclonal antibody (mAb), rituximab.
-
8. Zevalin, Inn-Ibritumomab Tiuxetan - European Medicines …
Link: https://www.ema.europa.eu/en/documents/scientific-discussion/zevalin-epar-scientific-discussion_en.pdf
Description: WebZevalin, Inn-Ibritumomab Tiuxetan. SCIENTIFIC DISCUSSION. This module reflects the initial scientific discussion for the approval of Zevalin. For information on changes after approval please refer to module 8. 1. Introduction. Non-Hodgkin Lymphomas (NHL) as a group is the most common malignant haematologic disease.
-
9. Y-90 Zevalin Uses, Side Effects & Warnings - Drugs.com
Link: https://www.drugs.com/mtm/y-90-zevalin.html
Description: WebMar 20, 2024 · What is Y-90 Zevalin? Y-90 Zevalin is a protein that targets white blood cells in the body. When this medicine is attached to a radioactive chemical, the radiation is delivered directly to the tumor . Y-90 Zevalin is used in combination with other medicines to treat non-Hodgkin's lymphoma.
-
10. FDA Approves Zevalin™ for Low-Grade Non-Hodgkin’s Lymphoma
Link: https://news.cancerconnect.com/non-hodgkins-lymphoma/fda-approves-zevalin-for-low-grade-non-hodgkin-s-lymphoma
Description: WebMar 8, 2009 · Non Hodgkins Lymphoma Treatment. The Food and Drug Administration (FDA) has approved Zevalin™ for the treatment of low-grade Non-Hodgkin’s lymphoma that has stopped responding to standard therapies. The approval indicates that Zevalin™ must be used in combination with Rituxan™.